Subscribe
Magazine
Videos
Advertise
About Us
Smart Water Summit
Wastewater Summit
Drinking Water
Smart Water
Asset Management
Water Utility Management
Water Reuse
Global Thought Leaders
Podcast
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
WaterWorld Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Edesa Biotech Inc
(NQ:
EDSA
)
4.500
UNCHANGED
Streaming Delayed Price
Updated: 11:26 AM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Edesa Biotech Inc
< Previous
1
2
3
4
5
Next >
Edesa Biotech Reports Statistically Significant Mortality Reductions in Phase 2 ARDS Drug Study
September 30, 2022
Via
ACCESSWIRE
Edesa Biotech to Present at Upcoming H.C. Wainwright Investor Conference
September 08, 2022
Via
ACCESSWIRE
Edesa Biotech Reports Phase 2b Study Reaches Full Enrollment
September 07, 2022
Via
ACCESSWIRE
Edesa Biotech Reports Fiscal 3rd Quarter 2022 Results
August 12, 2022
Via
ACCESSWIRE
Edesa Biotech to Participate at the Upcoming BTIG Biotech Conference
August 03, 2022
Via
ACCESSWIRE
Edesa Biotech Adds Mechanically Ventilated Patients To Late-Stage COVID-19 Study
May 24, 2022
Via
Benzinga
Recap: Edesa Biotech Q4 Earnings
December 28, 2021
Edesa Biotech (NASDAQ:EDSA) reported its Q4 earnings results on Tuesday, December 28, 2021 at 04:15 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Edesa Biotech to Present at ARDS Drug Development Summit
July 11, 2022
TORONTO, ON / ACCESSWIRE / July 11, 2022 / Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, announced today that Par...
From
Edesa Biotech
Via
AccessWire
Stocks That Hit 52-Week Lows On Tuesday
June 28, 2022
On Tuesday, 87 companies hit new 52-week lows.
Via
Benzinga
Edesa Biotech Adds Mechanically Ventilated Patients to Phase 3 ARDS Study
May 24, 2022
TORONTO, ON / ACCESSWIRE / May 24, 2022 / Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today announced that the...
From
Edesa Biotech
Via
AccessWire
Exposures
COVID-19
Edesa Biotech to Present at H.C. Wainwright Global Investment Conference
May 19, 2022
TORONTO, ON / ACCESSWIRE / May 19, 2022 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, announced today that Par...
From
Edesa Biotech
Via
AccessWire
Edesa Biotech Reports Fiscal 2nd Quarter 2022 Results
May 13, 2022
TORONTO, ON / ACCESSWIRE / May 13, 2022 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today reported financial...
From
Edesa Biotech
Via
AccessWire
Exposures
COVID-19
Edesa Biotech Reports Dermatitis Study Enrolling Faster than Expected
April 28, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
Edesa Biotech
Via
AccessWire
Edesa Biotech Appoints Strategy Expert to Board of Directors
March 29, 2022
TORONTO, ON / ACCESSWIRE / March 29, 2022 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today announced the...
From
Edesa Biotech
Via
AccessWire
Edesa Biotech Announces Closing of $10.0 Million Registered Direct Offering
March 24, 2022
TORONTO, ON / ACCESSWIRE / March 24, 2022 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today announced the...
From
Edesa Biotech
Via
AccessWire
Edesa Biotech Announces $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
March 22, 2022
TORONTO, ON / ACCESSWIRE / March 22, 2022 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today announced that it...
From
Edesa Biotech
Via
AccessWire
Edesa Biotech Reports Enrollment Milestone in Phase 3 ARDS Study
February 17, 2022
TORONTO, ON / ACCESSWIRE / February 17, 2022 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today provided an...
From
Edesa Biotech
Via
AccessWire
Exposures
COVID-19
66 Biggest Movers From Yesterday
March 23, 2022
Gainers JX Luxventure Limited (NASDAQ: LLL) shares jumped 119.5% to settle at $4.39 on Tuesday after the company announced it signed a $60 million sales agreement. Forge Global...
Via
Benzinga
Edesa Biotech Reports Fiscal 1st Quarter 2022 Results
February 14, 2022
TORONTO, ON / ACCESSWIRE / February 14, 2022 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today reported...
From
Edesa Biotech
Via
AccessWire
Exposures
COVID-19
Edesa Biotech to Join Ontario Bioscience Panel Discussion
January 26, 2022
TORONTO, ON / ACCESSWIRE / January 26, 2022 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, announced today that Dr....
From
Edesa Biotech
Via
AccessWire
Exposures
COVID-19
Canada Approves Edesa Biotech's COVID-19 Trial For EB05 Antibody As Rescue Therapy
January 13, 2022
Health Canada has approved to test Edesa Biotech Inc's (NASDAQ: EDSA) monoclonal antibody candidate, designated EB05, as COVID-19 rescue therapy for critically...
Via
Benzinga
Edesa Biotech Receives Canadian Approval to Test COVID-19 Drug as Rescue Therapy
January 13, 2022
- Phase 3 study will focus on critically ill patients, many of whom have run out of effective drug treatment options TORONTO, ON / ACCESSWIRE / January 13, 2022 / Edesa Biotech, Inc. (NASDAQ:EDSA), a...
From
Edesa Biotech
Via
AccessWire
Exposures
COVID-19
5 Stocks To Watch For Wednesday, December 29, 2021
December 29, 2021
5 stocks you that you should keep in mind today.
Via
Talk Markets
5 Stocks To Watch For December 29, 2021
December 29, 2021
Some of the stocks that may grab investor focus today are: Cal-Maine Foods (NASDAQ: CALM) reported weaker-than-expected earnings for its second quarter on Tuesday. Cal-Maine...
Via
Benzinga
Edesa Biotech Reports Fiscal Year 2021 Results
December 28, 2021
TORONTO, ON / ACCESSWIRE / December 28, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today reported...
From
Edesa Biotech
Via
AccessWire
Exposures
COVID-19
Edesa Biotech Marks Enrollment Milestone in Dermatitis Study
December 01, 2021
TORONTO, ON / ACCESSWIRE / December 1, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today announced that it...
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Edesa Biotech Extends COVID-19 Clinical Study to Poland
November 04, 2021
- Expansion to European Union country follows favorable Phase 2 results - Company focusing on critically ill hospitalized patients TORONTO, ON / ACCESSWIRE / November 4, 2021 / Edesa Biotech, Inc....
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2021
December 20, 2021
Upgrades According to Keefe, Bruyette & Woods, the prior rating for Old National Bancorp (NASDAQ:...
Via
Benzinga
Edesa Biotech Shares Gain As Its COVID-19 Antibody Shows Favorable Mortality Reductions
October 19, 2021
Edesa Biotech Inc (NASDAQ: EDSA) has announced additional results from the Phase 2 part of an ongoing Phase 2/3 study of EB05 as a single-dose treatment for hospitalized...
Via
Benzinga
Exposures
COVID-19
Edesa Biotech Is Now Above Resistance: Can It Continue Higher?
October 19, 2021
Edesa Biotech Inc. (NASDAQ: EDSA) shares are trading higher Tuesday after the company announced additional results from the Phase 2 part of the ongoing Phase 2/3 study of EB05 in...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.